PremiumMarket NewsEli Lilly Strikes $870 Million Deal to Develop Long-Acting Obesity Treatments Roche’s Chugai Seeks Next Milestone after Finding Success with Eli Lilly’s Obesity Drug Eli Lilly’s obesity drug sales rise in India, Bloomberg reports PremiumThe FlySalesforce initiated, Dollar Tree upgraded: Wall Street’s top analyst calls Eli Lilly downgraded to Hold from Buy at Erste Group Eli Lilly Stock (LLY) Grows Despite U.K. Warnings to Pregnant Women Over Weight Loss Jabs PremiumThe FlyNxera Pharma achieves development milestone in collaboration with Eli Lilly Winners and Losers: Energy Stocks Soared and Healthcare Crashed in May BMO Capital Markets Reiterates ‘Buy’ Rating on Eli Lilly Stock (LLY) 
